Surveillance colonoscopy

Technical report

From Cancer Guidelines Wiki


This Technical Report accompanies the Clinical practice guidelines for Surveillance Colonoscopy, developed by Cancer Council Australia.

It outlines the guideline development process and methodology, lists the clinical questions, provides all accompanying NHMRC Statement Forms, the detailed technical documentation for each question and the risk of bias assessment tools used to assess the included literature as a result of a systematic review.

Guideline development process[edit source]

Clinical question list[edit source]

Evidence statement forms, systematic review reports and modelling reports[edit source]

The following reports are for questions that were answered by a new systematic literature review or modelling. The associated technical documentation appears at the bottom of the relevant content pages.

The questions were given alphanumeric codes when they were developed, please refer to the codes below and see the Clinical question list for more detail.


SAD1: What should be the surveillance colonoscopy for patients are low risk (1-2 small <10mm tubular adenomas)?
Evidence statement form SAD1
Systematic review report SAD1


SAD2: What should be the surveillance colonoscopy for patients at high risk (size ≥10mm, HGD, villosity and/or 3-4 adenomas)?
Evidence statement form SAD2
Systematic review report SAD2


SAD3: What is the appropriate colonscopic surveillance after the removal of large sessile or laterally spreading adenomas?
Evidence statement form SAD3
Systematic review report SAD3


SAD4: What is the appropriate colonoscopic surveillance after the identification of sessile serrated adenomas and traditional serrated adenomas?
Evidence statement form SAD4
Systematic review report SAD4


SAD5: What should be the surveillance colonoscopy for patients with adenoma multiplicity?
Evidence statement form SAD5
Systematic review report SAD5


SFH1: Is the surveillance colonoscopy recommendation different for patients with adenomas who also have a family history of CRC?
Evidence statement form SFH1
Systematic review report SFH1


COL1: What is the role of pre or peri-operative colonoscopy in CRC patients?
Evidence statement form COL1
Systematic review report COL1


FUC1: At what time points after CRC resection should surveillance colonoscopy be performed?
Systematic review report FUC1


SUR1: What is the appropriate time to commence surveillance in IBD patients (ulcerative colitis and Crohn’s patients, and effects of primary sclerosing cholangitis or family history of CRC)?
Evidence statement form SUR1
Systematic review report SUR1


SUR2: What is the most appropriate time interval for surveillance in IBD patients based on risk?
Evidence statement form SUR2
Systematic review report SUR2


SUR3: What is the recommended surveillance strategies for surveillance in IBD patients?
Evidence statement form SUR3
Systematic review report SUR3


MNG1: What should be the protocol to manage elevated dysplasia in IBD?
Evidence statement form MNG1-4
Systematic review report MNG1


MNG2: What should be the protocol to manage high grade dysplasia in IBD?
Evidence statement form MNG1-4
Systematic review report MNG2


MNG3: What should be the protocol to manage low grade dysplasia in IBD?
Evidence statement form MNG1-4
Systematic review report MNG3


MNG4: What should be the protocol to manage indefinite dysplasia in IBD?
Evidence statement form MNG1-4
Systematic review report MNG4

Back to top